Karyopharm Therapeutics (KPTI) Q3 2024 Earnings

Aug 6Confirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.36
-0.31
-0.25
-0.2

Details

Expected EPS
-0.297857
Actual EPS
-0.2
Surprise EPS
0.1
Surprise Percent
+32.85%

Description

⁨Karyopharm Therapeutics⁩ (⁦KPTI⁩) has reported earnings of ⁦-0.2⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts